跳至主要内容
临床试验/NL-OMON35064
NL-OMON35064已完成不适用

A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects. - [14C]-GSK633 microdose study

GlaxoSmithKline0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - healthy male volunteers
  • - age between 18 and 50 years
  • - body weight is 50 kg or more and BMI is between 18.5 and 29.9 kg/m2
  • - non smoker (have not smoked for at least 6 months and/or have not smoked for a period of 10 years with a maximum of 10 cigarettes or equivalent per day or a period of 5 years with a maximum of 20 cigarettes or equivalent per day prior to study drug administration

排除标准

  • Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.

研究者

相似试验